Intrinsic Value
Regulus Therapeutics Inc. (RGLS)
$2.89
+0.01 (+0.35%)
Enterprise Value | -2,942.63 |
---|---|
Net Debt | -20.73 |
Equity Value | -2,921.91 |
Shares Outstanding | 18.96 |
Equity Value Per Share | -154.11 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt